Nomura Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.2M Buy
1,006,124
+16,853
+2% +$1.47M 0.2% 91
2026
Q1
$84.3M Sell
989,271
-17,350
-2% -$1.55M 0.22% 91
2025
Q4
$79.5M Buy
1,006,621
+126,573
+14% +$9.92M 0.2% 93
2025
Q3
$70.4M Sell
880,048
-21,954
-2% -$1.87M 0.18% 111
2025
Q2
$82M Sell
902,002
-22,382
-2% -$2.04M 0.22% 96
2025
Q1
$86.6M Buy
924,384
+44,252
+5% +$3.96M 0.27% 79
2024
Q4
$80M Buy
880,132
+28,322
+3% +$2.7M 0.24% 83
2024
Q3
$88.4M Sell
851,810
-27,070
-3% -$2.76M 0.27% 84
2024
Q2
$85.3M Sell
878,880
-17,448
-2% -$1.61M 0.29% 74
2024
Q1
$80.7M Sell
896,328
-45,424
-5% -$3.85M 0.29% 78
2023
Q4
$75.1M Buy
941,752
+1,243
+0.1% +$93.5K 0.31% 72
2023
Q3
$66.9M Buy
940,509
+76,682
+9% +$5.73M 0.31% 67
2023
Q2
$66.5M Buy
863,827
+184,866
+27% +$14.3M 0.31% 66
2023
Q1
$51M Buy
678,961
+246,815
+57% +$18.4M 0.27% 86
2022
Q4
$34M Sell
432,146
-30,106
-7% -$2.26M 0.2% 120
2022
Q3
$32.5M Buy
462,252
+19,136
+4% +$1.5M 0.21% 110
2022
Q2
$35.5M Buy
443,116
+38,449
+10% +$3.01M 0.22% 102
2022
Q1
$30.7M Buy
404,667
+2,940
+0.7% +$233K 0.17% 132
2021
Q4
$34.3M Sell
401,727
-6,906
-2% -$539K 0.17% 122
2021
Q3
$30.9M Buy
408,633
+22,338
+6% +$1.77M 0.17% 128
2021
Q2
$31.4M Buy
386,295
+564
+0.1% +$46.1K 0.18% 126
2021
Q1
$30.4M Buy
385,731
+7,774
+2% +$609K 0.19% 117
2020
Q4
$32.3M Buy
377,957
+2,905
+0.8% +$240K 0.22% 100
2020
Q3
$28.9M Buy
375,052
+40,087
+12% +$3.06M 0.22% 97
2020
Q2
$24.5M Buy
334,965
+46,430
+16% +$3.3M 0.21% 105
2020
Q1
$19.1M Sell
288,535
-29,005
-9% -$2.05M 0.2% 111
2019
Q4
$21.9M Buy
317,540
+11,409
+4% +$778K 0.2% 112
2019
Q3
$22.5M Buy
306,131
+22,416
+8% +$1.63M 0.21% 106
2019
Q2
$20.3M Buy
283,715
+6,086
+2% +$432K 0.2% 104
2019
Q1
$19M Buy
277,629
+7,918
+3% +$511K 0.19% 113
2018
Q4
$16.1M Buy
269,711
+20,561
+8% +$1.29M 0.18% 121
2018
Q3
$16.7M Buy
249,150
+12,240
+5% +$815K 0.16% 127
2018
Q2
$15.4M Buy
236,910
+8,346
+4% +$546K 0.16% 128
2018
Q1
$16.4M Buy
228,564
+62,039
+37% +$4.46M 0.18% 118
2017
Q4
$12.6M Buy
166,525
+9,626
+6% +$703K 0.15% 141
2017
Q3
$11.4M Buy
156,899
+5,000
+3% +$360K 0.15% 143
2017
Q2
$11.3M Sell
151,899
-14,071
-8% -$1.04M 0.15% 148
2017
Q1
$12.1M Sell
165,970
-30,352
-15% -$2.12M 0.17% 136
2016
Q4
$12.8M Buy
196,322
+9,680
+5% +$664K 0.23% 104
2016
Q3
$13.8M Buy
186,642
+4,840
+3% +$358K 0.25% 99
2016
Q2
$13.3M Sell
181,802
-860
-0.5% -$61.2K 0.25% 98
2016
Q1
$12.9M Buy
182,662
+15,590
+9% +$1.04M 0.25% 107
2015
Q4
$11.1M Sell
167,072
-21,654
-11% -$1.44M 0.22% 122
2015
Q3
$12M Sell
188,726
-15,178
-7% -$992K 0.24% 112
2015
Q2
$13.3M Sell
203,904
-7,510
-4% -$509K 0.25% 111
2015
Q1
$14.7M Sell
211,414
-11,448
-5% -$791K 0.26% 109
2014
Q4
$15.5M Sell
222,862
-6,593
-3% -$445K 0.27% 101
2014
Q3
$15M Sell
229,455
-5,680
-2% -$375K 0.26% 98
2014
Q2
$16M Sell
235,135
-3,190
-1% -$214K 0.3% 94
2014
Q1
$15.5M Buy
238,325
+30,779
+15% +$1.94M 0.28% 92
2013
Q4
$13.5M Sell
207,546
-17,347
-8% -$1.11M 0.24% 109
2013
Q3
$13.3M Sell
224,893
-78,950
-26% -$4.68M 0.25% 110
2013
Q2
$17.4M Buy
+303,843
New +$18M 0.34% 66

Other funds holding CL

Nomura Asset Management's CL Position: Q2 2026 in Review

Nomura Asset Management increased its Colgate-Palmolive (CL) stake by 1.7% in Q2 2026, buying an estimated $1.47M and bringing the position to 1,006,124 shares worth $92.2M. The position accounts for 0.2% of the portfolio, ranked #91.

Nomura Asset Management first reported a position in CL in Q2 2013 and has held it in 53 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Nomura Asset Management held 1,006,124 shares of Colgate-Palmolive worth $92.2M as of Q2 2026.
  • Nomura Asset Management bought 16,853 Colgate-Palmolive shares in Q2 2026, an estimated $1.47M.
  • Colgate-Palmolive made up 0.2% of Nomura Asset Management's portfolio in Q2 2026, its #91 holding.
  • Nomura Asset Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.